Biomed Industries, Inc.

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.biomedind.com

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

First Posted Date
2024-12-13
Last Posted Date
2024-12-17
Lead Sponsor
Biomed Industries, Inc.
Target Recruit Count
224
Registration Number
NCT06732245
Locations
🇺🇸

Biomed Research Unit #90067-102, Los Angeles, California, United States

🇺🇸

Biomed Research Unit # 92121-103, San Diego, California, United States

🇺🇸

Biomed Research Unit # 94104-101, San Francisco, California, United States

and more 14 locations

Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus

First Posted Date
2024-09-27
Last Posted Date
2024-09-27
Lead Sponsor
Biomed Industries, Inc.
Target Recruit Count
74
Registration Number
NCT06615700
Locations
🇦🇺

Biomed Industries Pty Limited- Clinical Testing Site 1, Camperdown, New South Wales, Australia

🇦🇺

Biomed Industries, Pty Limited Testing Site 2, Parkville, Victoria, Australia

Phase 2 Trials of NA-931 to Study Subjects Who Are Obese With at Least One Weight-related Comorbid Condition

First Posted Date
2024-08-21
Last Posted Date
2024-08-21
Lead Sponsor
Biomed Industries, Inc.
Target Recruit Count
125
Registration Number
NCT06564753
Locations
🇦🇺

Biomed Investigational Site, Melbourne, Victoria, Australia

A Phase 3 Randomized Double Blind Efficacy and Safety Study of Oral Polio Vaccine and NA-831 for Covid-19

First Posted Date
2020-09-07
Last Posted Date
2020-09-09
Lead Sponsor
Biomed Industries, Inc.
Target Recruit Count
3600
Registration Number
NCT04540185
Locations
🇺🇸

Coronavirus Research Institute- Testing Site, Los Angeles, California, United States

🇺🇸

Coronavirus Research Institute, Sunnyvale, California, United States

🇺🇸

Coronavirus Research Testing Site, San Francisco, California, United States

and more 4 locations

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

First Posted Date
2020-06-30
Last Posted Date
2022-02-16
Lead Sponsor
Biomed Industries, Inc.
Target Recruit Count
525
Registration Number
NCT04452565
Locations
🇺🇸

Coronavirus Research Institute, Orange, California, United States

🇺🇸

Coronavirus Research Institute- Testing Site, Fort Sam Houston, Texas, United States

🇺🇸

Coronavirus Research Institute-Testing Site, Tacoma, Washington, United States

and more 2 locations

A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831

First Posted Date
2018-05-29
Last Posted Date
2020-06-30
Lead Sponsor
Biomed Industries, Inc.
Target Recruit Count
126
Registration Number
NCT03538522
Locations
🇳🇿

NeuroActiva Testing Facility of NeuroActiva (New Zealand) Ltd, Auckland, New Zealand

🇳🇿

NeuroActiva-Clinical Research Unit, Auckland, New Zealand

© Copyright 2024. All Rights Reserved by MedPath